These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 24407056)

  • 1. Are paraphenylenediamine and benzocaine relevant markers of sulfasalazine allergy?
    Audran MJ; Lepoittevin JP; Pajot C; Martin L
    Dermatitis; 2014; 25(1):40-1. PubMed ID: 24407056
    [No Abstract]   [Full Text] [Related]  

  • 2. Is p-phenylenediamine a marker of sulfasalazine allergy?
    Kenani Z; Lahouel I; Belhadjali H; Soua Y; Aouam K; Youssef M; Zili J
    Contact Dermatitis; 2018 Feb; 78(2):173-174. PubMed ID: 29341189
    [No Abstract]   [Full Text] [Related]  

  • 3. Cross-reactions among parabens, para-phenylenediamine, and benzocaine: a retrospective analysis of patch testing.
    Turchin I; Moreau L; Warshaw E; Sasseville D
    Dermatitis; 2006 Dec; 17(4):192-5. PubMed ID: 17150168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rash and fever after sulfasalazine use.
    Raithatha N; Mehrtens S; Mouyis M; Manson J
    BMJ; 2014 Oct; 349():g5655. PubMed ID: 25296685
    [No Abstract]   [Full Text] [Related]  

  • 5. Cyclooxygenase inhibitors and cardiovascular risk.
    Andersohn F; Suissa S; Garbe E
    JAMA; 2007 Feb; 297(6):586-7; author reply 587-8. PubMed ID: 17299191
    [No Abstract]   [Full Text] [Related]  

  • 6. Celecoxib-induced erythema multiforme-type drug eruption with a positive patch test.
    Arakawa Y; Nakai N; Katoh N
    J Dermatol; 2011 Dec; 38(12):1185-8. PubMed ID: 22103805
    [No Abstract]   [Full Text] [Related]  

  • 7. [Sulfasalazine-induced DRESS syndrome associated with Epstein Barr virus reactivation].
    Zaïem A; Aouinti I; Lakhoua G; Sahnoun R; Daghfous R; Lakhal M; El Aïdli S
    Therapie; 2013; 68(5):321-3. PubMed ID: 24225043
    [No Abstract]   [Full Text] [Related]  

  • 8. Sulfasalazine-induced linear immunoglobulin A bullous dermatosis with DRESS.
    Hernández N; Borrego L; Soler E; Hernández J
    Actas Dermosifiliogr; 2013 May; 104(4):343-6. PubMed ID: 23562401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesalazine and para-phenylenediamine allergy.
    Charles J; Bourrain JL; Tessier A; Lepoittevin JP; Beani JC
    Contact Dermatitis; 2004; 51(5-6):313-4. PubMed ID: 15606661
    [No Abstract]   [Full Text] [Related]  

  • 10. Types of sensitization disclosed by positive patch tests to paraphenylenediamine and benzocaine.
    GAUL LE
    Ann Allergy; 1960 Jul; 18():738-45. PubMed ID: 13826899
    [No Abstract]   [Full Text] [Related]  

  • 11. Benefit versus risk in the use of non-selective NSAIDs and selective COX-2 inhibitors.
    Aalbers J
    Cardiovasc J Afr; 2012 Jul; 23(6):356. PubMed ID: 23091830
    [No Abstract]   [Full Text] [Related]  

  • 12. A Teenager With Sulfasalazine-Associated DRESS Syndrome After the Introduction of Amoxicillin.
    Sussman S; Devlin V; Dimitriades VR
    Clin Pediatr (Phila); 2017 Mar; 56(3):290-291. PubMed ID: 27356629
    [No Abstract]   [Full Text] [Related]  

  • 13. Does contact allergy to benzocaine cause orodynia?
    ; De D; Handa S
    Indian J Dermatol Venereol Leprol; 2015; 81(1):84-6. PubMed ID: 25566916
    [No Abstract]   [Full Text] [Related]  

  • 14. Selective use of selective nonsteroidal anti-inflammatory drugs in inflammatory bowel disease.
    Korzenik JR; Podolsky DK
    Clin Gastroenterol Hepatol; 2006 Feb; 4(2):157-9. PubMed ID: 16469674
    [No Abstract]   [Full Text] [Related]  

  • 15. Allergic contact dermatitis to benzocaine: the importance of concomitant positive patch test results.
    González-Rodríguez AJ; Gutiérrez-Paredes EM; Revert Fernández Á; Jordá-Cuevas E
    Actas Dermosifiliogr; 2013 Mar; 104(2):156-8. PubMed ID: 22551703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sulfasalazine-induced aseptic meningitis with positive rechallenge: a case report and review of the literature.
    Salouage I; El Aïdli S; Cherif F; Kastalli S; Zaiem A; Daghfous R
    Therapie; 2013; 68(6):423-6. PubMed ID: 24356191
    [No Abstract]   [Full Text] [Related]  

  • 17. [Innovation of anti-inflammatory drugs--inhibition of cyclooxygenases].
    Guo ZR
    Yao Xue Xue Bao; 2005 Nov; 40(11):967-9. PubMed ID: 16499077
    [No Abstract]   [Full Text] [Related]  

  • 18. Consort contact dermatitis to paraphenylenediamine, with an unusual clinical presentation of tumid plaques.
    Veysey EC; Burge S; Cooper S
    Contact Dermatitis; 2007 Jun; 56(6):366-7. PubMed ID: 17577386
    [No Abstract]   [Full Text] [Related]  

  • 19. Commentary: risk factors for gastrointestinal bleeding in NSAID users.
    Hawkey CJ
    Aliment Pharmacol Ther; 2012 Nov; 36(9):904; discussion 905. PubMed ID: 23163560
    [No Abstract]   [Full Text] [Related]  

  • 20. [Contact cutaneous allergy in 100 cases of varicose ulcers].
    Malten KE; Kuiper JP
    Phlebologie; 1974; 27(4):417-20. PubMed ID: 4460050
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.